They were diagnosed with cancer, sued Bayer. The pharmaceutical giant triumphs in court

A jury in St. Louis ruled in favor of Bayer's Monsanto in a case related to Roundup, following a Supreme Court decision that limited claims regarding herbicide labeling. This verdict poses challenges for future lawsuits against Bayer, which has faced significant financial burdens from Roundup-related litigation since acquiring Monsanto in 2018. The case involved three women who claimed their non-Hodgkin lymphoma was linked to Roundup use, with one passing away before the trial. Bayer maintains that extensive studies support glyphosate's safety and denies any wrongdoing. The Supreme Court ruling emphasized that federal law requires EPA-approved labels, which do not mandate cancer warnings, complicating plaintiffs' arguments.